| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |